Page last updated: 2024-10-24

cefixime and Heart Septal Defects, Ventricular

cefixime has been researched along with Heart Septal Defects, Ventricular in 1 studies

Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.

Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwata, S1
Yokota, T1
Kusumoto, Y1
Shiro, H1
Sato, Y1
Akita, H1
Nanri, S1
Oikawa, T1
Ishikawa, K1
Kumagai, N1

Other Studies

1 other study available for cefixime and Heart Septal Defects, Ventricular

ArticleYear
[The effect of cefixime (CFIX) on intestinal bacterial flora].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1986, Volume: 60, Issue:6

    Topics: Bronchitis; Bronchopneumonia; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Resistance, Microb

1986